Page 47 - Read Online

Jain et al. Rare Dis Orphan Drugs J 2024;3:8 https://dx.doi.org/10.20517/rdodj.2023.42 Page 7 of 9

Contributed to the writing of the manuscript: Foster L, Nishimura Y, Li EY, Tsang KP
All authors contributed to the review and editing of the manuscript.

Availability of data and materials
Not applicable.

Financial support and sponsorship
None.

Conflicts of interest
All authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2024.

REFERENCES
1. Asia population 2024. Available from: https://worldpopulationreview.com/continents/asia-population [Last accessed on 28 Feb
2024].
2. News & insights. Rare disease care across Asia Pacific. 2023. Available from: https://sandpipercomms.com/health/rare-disease-care-
across-asia-pacific/ [Last accessed on 28 Feb 2024].
3. Jain R. Rare diseases in Asia and the Pacific must be tackled too. Asia Pathways. 2020. Available from: https://www.asiapathways-
adbi.org/2020/07/rare-diseases-asia-pacific-must-be-tackled-too/ [Last accessed on 28 Feb 2024].
4. The Economist Intelligence Unit. Suffering in silence: assessing rare disease awareness and management in Asia-Pacific. 2020.
Available from: https://www.cslbehring.com.au/-/media/shared/economist-white-paper/eng_white-paper_a4_digital_final.pdf [Last
accessed on 28 Feb 2024].
5. Shafie AA, Supian A, Hassali MAA, et al. Correction: rare disease in Malaysia: challenges and solutions. PLoS One
2022;17:e0273939. DOI PubMed PMC
6. Chung CCY, Hong Kong Genome Project; Chu ATW; Chung BHY. Rare disease emerging as a global public health priority. Front
Public Health 2022;10:1028545. DOI PubMed PMC
7. Shafie AA, Chaiyakunapruk N, Supian A, Lim J, Zafra M, Hassali MAA. State of rare disease management in Southeast Asia.
Orphanet J Rare Dis 2016;11:107. DOI PubMed PMC
8. Wong-Rieger D, Claxton W, Vines R, Padilla C, Tsang KP, Hickinbotham L. An Asia pacific alliance for rare diseases. Patient
2015;8:11-7. DOI
9. Dharssi S, Wong-Rieger D, Harold M, Terry S. Review of 11 national policies for rare diseases in the context of key patient needs.
Orphanet J Rare Dis 2017;12:63. DOI PubMed PMC
10. Khosla N, Valdez R. A compilation of national plans, policies and government actions for rare diseases in 23 countries. Intractable
Rare Dis Res 2018;7:213-22. DOI PubMed PMC
11. Chan AYL, Chan VKY, Olsson S, et al. Access and unmet needs of orphan drugs in 194 countries and 6 areas: a global policy review
with content analysis. Value Health 2020;23:1580-91. DOI
12. Gammie T, Lu CY, Babar ZU. Access to orphan drugs: a comprehensive review of legislations, regulations and policies in 35
countries. PLoS One 2015;10:e0140002. DOI PubMed PMC
13. Manatū Hauora. Rare disorders strategy. Available from: https://www.health.govt.nz/our-work/diseases-and-conditions/rare-disorders-
strategy [Last accessed on 28 Feb 2024].
14. UNFPA. Population trends. Available from: https://asiapacific.unfpa.org/en/populationtrends#:~:text=The%20Asia%20and%20the%
20Pacific,populous%20countries%2C%20China%20and%20India [Last accessed on 29 Feb 2024].
15. Statista. Total population in the Asia-Pacific region in 2022, by country or territory. Available from: https://www.statista.com/
statistics/632565/asia-pacific-total-population-by-country/ [Last accessed on 28 Feb 2024].
16. Ministry of Health and Family Welfare. Steps taken for treatment of patients suffering from rare diseases. 2023. Available from: https:/